{"data":{"id":"us-ct/conn.-gen.-stat.-17b-491b","jurisdiction":"us-ct","citation":"Conn. Gen. Stat. § 17b-491b","heading":"Reimbursement formula for drugs used to treat hemophilia A.","body":"The maximum allowable cost paid for antihemophilic Factor VII, VIII, IX and X products under the Medicaid program shall be the actual acquisition cost as reflected on the manufacturer's invoice plus eight per cent plus the professional dispensing fee established for covered outpatient drugs.","path":["TITLE 17b. SOCIAL SERVICES","CHAPTER 319ff. PRESCRIPTION DRUG ASSISTANCE"],"source_url":"https://www.cga.ct.gov/current/pub/chap_319ff.htm#sec_17b-491b","current_through":"Revised to January 1, 2026 (2026 Supplement to the General Statutes of Connecticut, applied over the base revision of January 1, 2025)","vintage":"","retrieved_at":"2026-09-06T19:07:02Z","sha256":"f44a4f2b7e9d784cc10b118e35bf0c905d735793e9c57f8e0d22cda015ebbbfe","source_id":"us-ct","stale":false,"prev":"us-ct/conn.-gen.-stat.-17b-491a","next":"us-ct/conn.-gen.-stat.-17b-491c"},"notice":"GroundRules: Original legal text. Not legal advice."}